Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Melbourne Health National Health and Medical Research Council, Australia |
---|---|
Information provided by: | Melbourne Health |
ClinicalTrials.gov Identifier: | NCT00241956 |
To assess whether patients with diabetes have less clinical improvement during inpatient rehabilitation than those without diabetes and whether hyperglycaemia during rehabilitation is an adverse prognostic indicator.
Condition |
---|
Cerebrovascular Accident Diabetes Hyperglycemia |
Study Type: | Observational |
Study Design: | Retrospective |
Official Title: | Impact of Diabetes and Glucose Control During Rehabilitation After Stroke |
Estimated Enrollment: | 120 |
Study Start Date: | October 2005 |
Patients with diabetes have a higher mortality rate and more severe disability from stroke compared to those without diabetes. Those with hyperglycaemia tend to progress to a larger final stroke size. Diabetes and hyperglycaemia may affect the ability of the patient to clinically improve, independent of the degree of initial impairment. We will perform a retrospective review of medical records of stroke patients admitted to an inpatient rehabilitation unit. We will compare outcomes of changes in disability scales (FIM and Barthel) from admission to discharge, length of stay and hospital events between those with and without diabetes. Amongst those with diabetes, we will also assess whether those with higher mean blood glucose levels during their inpatient rehabilitation stay have worse outcomes.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Australia, Victoria | |
The Royal Melbourne Hospital | |
Melbourne, Victoria, Australia, 3050 |
Principal Investigator: | Leo Rando, MBBS FRACP | Melbourne Health |
Study ID Numbers: | 2004.246 |
Study First Received: | October 18, 2005 |
Last Updated: | February 3, 2009 |
ClinicalTrials.gov Identifier: | NCT00241956 History of Changes |
Health Authority: | Australia: Department of Health and Ageing Therapeutic Goods Administration |
Metabolic Diseases Cerebral Infarction Stroke Vascular Diseases Diabetes Mellitus Central Nervous System Diseases Endocrine System Diseases Ischemia Brain Diseases |
Cerebrovascular Disorders Hyperglycemia Brain Ischemia Endocrinopathy Brain Infarction Infarction Glucose Metabolism Disorders Metabolic Disorder |
Metabolic Diseases Cerebral Infarction Stroke Nervous System Diseases Vascular Diseases Diabetes Mellitus Endocrine System Diseases Central Nervous System Diseases |
Brain Diseases Cerebrovascular Disorders Hyperglycemia Brain Ischemia Cardiovascular Diseases Brain Infarction Glucose Metabolism Disorders |